Oxygen radicals and neuropsychiatric illness. Some speculations
- PMID: 1845228
- DOI: 10.1001/archpsyc.1991.01810360061009
Oxygen radicals and neuropsychiatric illness. Some speculations
Abstract
Free radicals are reactive chemical species with an unpaired electron that are produced through a variety of physiologic and pathologic processes. Free radicals have been implicated in a variety of neuropsychiatric conditions, many of which are marked by the gradual development of psychopathologic symptoms and movement disorder. There is evidence that radical-induced damage may be important in Parkinson's disease, tardive dyskinesia, metal intoxication syndromes, and Down's syndrome, and possibly also in schizophrenia, Huntington's disease, and Alzheimer's disease. Although some of this evidence is highly speculative, it may offer an avenue for further understanding and treatment of these conditions.
Similar articles
-
Free radical involvement in neuropsychiatric illnesses.Psychopharmacol Bull. 1995;31(1):159-65. Psychopharmacol Bull. 1995. PMID: 7675980 Review.
-
A unifying theory of movement and madness: involvement of free radicals in disorders of the isodendritic core of the brainstem.Med Hypotheses. 1988 Sep;27(1):59-63. doi: 10.1016/0306-9877(88)90085-0. Med Hypotheses. 1988. PMID: 3060706
-
Free radicals in brain metabolism and pathology.Br Med Bull. 1993 Jul;49(3):577-87. doi: 10.1093/oxfordjournals.bmb.a072632. Br Med Bull. 1993. PMID: 8221024 Review.
-
Free radicals and antioxidants.Lancet. 1994 Nov 19;344(8934):1441. Lancet. 1994. PMID: 7968106 No abstract available.
-
Metals and free radicals in neurodegeneration.Curr Opin Neurol. 1994 Dec;7(6):548-58. doi: 10.1097/00019052-199412000-00013. Curr Opin Neurol. 1994. PMID: 7866588 Review.
Cited by
-
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.Antioxid Redox Signal. 2011 Oct 1;15(7):2011-35. doi: 10.1089/ars.2010.3603. Epub 2011 Apr 21. Antioxid Redox Signal. 2011. PMID: 21126177 Free PMC article. Review.
-
Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics.Psychopharmacology (Berl). 2009 May;204(1):177-84. doi: 10.1007/s00213-008-1447-6. Epub 2009 Jan 13. Psychopharmacology (Berl). 2009. PMID: 19139851 Clinical Trial.
-
Associations between purine metabolites and clinical symptoms in schizophrenia.PLoS One. 2012;7(8):e42165. doi: 10.1371/journal.pone.0042165. Epub 2012 Aug 14. PLoS One. 2012. PMID: 22916123 Free PMC article.
-
Evaluation of oxidant, antioxidant, and S100B levels in patients with conversion disorder.Neuropsychiatr Dis Treat. 2016 Jul 13;12:1725-9. doi: 10.2147/NDT.S109174. eCollection 2016. Neuropsychiatr Dis Treat. 2016. PMID: 27471386 Free PMC article.
-
Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.CNS Drugs. 2001;15(4):287-310. doi: 10.2165/00023210-200115040-00004. CNS Drugs. 2001. PMID: 11463134 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical